Emergent Biosolutions (EBS.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Oct29

Emergent Biosolutions released FY2025 9 Months Earnings on October 29 After-Market EST, with actual revenue of USD 594.2 M and EPS of USD 1.8785

23:00

Emergent Biosolutions released FY2025 Q3 earnings on October 29 After-Market EST, actual revenue USD 231.1 M (forecast USD 199 M), actual EPS USD 0.91 (forecast USD -0.1328)

23:00

Oct22

Emergent Biosolutions to Release FY2025 Q3 Earnings on October 29 After-Market EST, Forecast Revenue USD 203.67 M, EPS USD -0.0203

00:16

Sep11

Emergent BioSolutions Inc. Reaches ACAM2000® Vaccine Contract with US Government

20:08

Aug20

Emergent BioSolutions Updates ANTHRASIL® Clinical Study for Anthrax Treatment

16:20

Aug10

Wall Street Zen downgrades Emergent Biosolutions stock rating

06:03

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 231.1 M, Net Income 51.2 M, EPS 0.91

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 140.9 M, Net Income -12 M, EPS -0.2214

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 222.2 M, Net Income 68 M, EPS 1.19

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More